UOWF
SRPT icon

University of Wisconsin Foundation’s Sarepta Therapeutics SRPT Stock Holding History

University of Wisconsin Foundation’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,717
Closed -$1.77M – 8
2025
Q1 		$1.77M Buy
+27,717
New +$2.92M 1.5% 8

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

University of Wisconsin Foundation's SRPT Position: Q2 2025 in Review

University of Wisconsin Foundation sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 27,717 shares — an estimated $1.77M sold.

University of Wisconsin Foundation first reported a position in SRPT in Q1 2025 and held it in 1 quarter. The position peaked at $1.77M in Q1 2025. 363 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • University of Wisconsin Foundation reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • University of Wisconsin Foundation sold 27,717 Sarepta Therapeutics shares in Q2 2025, an estimated $1.77M.
  • University of Wisconsin Foundation first reported a position in Sarepta Therapeutics in Q1 2025 and held it in 1 quarter.
  • University of Wisconsin Foundation's Sarepta Therapeutics position peaked at $1.77M in Q1 2025.
  • 363 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on University of Wisconsin Foundation's 13F filing for Q2 2025, filed 13 Aug 2025.